Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
ADHD Institute Register

The Meeting of Minds XII programme examined ADHD and comorbid mental health conditions across the lifespan, and covered topics such as: the ADHD brain; psychopharmacology of ADHD medications; behavioural addictions and comorbid substance-use disorder; ADHD in females and older adults; and the international consensus statement on ADHD. A variety of on-demand clinical hot topics were also available to attendees, covering the following themes: basic science; ADHD and comorbidity; optimal management of ADHD; and ADHD in a ‘digital world’.

ADHD clinical guidelines

Videos from Meeting of Minds X (Madrid, Spain, 17-18 April, 2018), a scientific forum initiated, organised and funded by Shire, now part of Takeda


Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan

Meeting of Minds 2020, Virtual Congress, 27 October – 23 November 2020

Week 1 of Meeting of Minds 2020 brought attendees interesting plenary sessions on ADHD as a dimensional disorder and the neurochemical pathways in the ADHD brain. Four clinical hot topics were also presented, which discussed: the behavioural and brain states in ADHD; the neurobiological consequences of abuse and neglect; how genetics can inform clinical practice in ADHD; and ADHD as a risk factor for COVID-19 infection.

Read more >



Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan

Meeting of Minds 2020, Virtual Congress, 27 October – 23 November 2020

Week 2 of Meeting of Minds 2020 brought attendees a stimulating plenary session on the psychopharmacology of ADHD medications and an ‘ask the experts’ discussion forum. Five clinical hot topics were also available, including: headlines from new publications in ADHD; psychological interventions across the lifespan; a deeper dive into the clinical psychopharmacology of ADHD medications; optimisation of pharmacological treatments for ADHD; and misuse of stimulants in clinical practice.

Read more >



Day 1 ‒ Advancing the management of ADHD across the lifespan

Meeting of Minds 2019, Munich, Germany, 5‒6 November

Day 1 of Meeting of Minds 2019 brought delegates interesting plenary sessions on the genetics and heritability of ADHD, entrepreneurship and ADHD, and ADHD and psychiatric comorbidities.

Read more >



Day 2 ‒ Advancing the management of ADHD across the lifespan

Meeting of Minds 2019, Munich, Germany, 5‒6 November

Day 2 of Meeting of Minds 2019 brought three insightful plenary sessions on ADHD in girls and women, recent headlines in ADHD and management optimisation of ADHD. A semi-plenary session for complex cases of ADHD regarding either children and adolescents or adults was also available for delegates.

Read more >



A selection of clinical seminars – advancing the management of ADHD across the lifespan

Meeting of Minds 2019, Munich, Germany, 5‒6 November

Delegates had the opportunity to attend a variety of interesting clinical seminars across a range of topics during the 11th Meeting of Minds.

Read more >



Day 1 – Advancing the science and clinical perspectives of ADHD across the life-course

March 2019; Job code: INTSP/C-ANPROM/NBU/16/0049d

Day 1 of Meeting of Minds 2018 brought the audience plenary sessions on advances in ADHD over the past decade, new clinical guidelines for ADHD, and challenges in the transition from child to adult mental health services.

Read more >



Day 2 – Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018, Madrid, Spain, 17–18 April

Day 2 of Meeting of Minds 2018 brought the audience two parallel plenary sessions, which covered optimising the management of ADHD in children, adolescents and adults with comorbid psychiatric disorders, key publications from 2017/2018, and the future of ADHD management.

Read more >



A selection of clinical seminars – Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018, Madrid, Spain, 17–18 April

Over the course of the 2-day meeting, delegates attended a series of clinical seminars on topics such as: ADHD and comorbid psychiatric disorders; psychopharmacology of ADHD medications; diagnostic issues and management of late-onset ADHD; ADHD treatment choice for children and adolescents; and ‘tips and tricks’ for greater success in patient consultations.

Read more >



Day 1 – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Day 1 of Meeting of Minds 2017 brought the audience exciting plenary sessions on the neurobiology of ADHD across the life-course; ADHD in girls and women; and the consequences of untreated ADHD.

Read more >



Day 2 – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Day 2 of Meeting of Minds 2017 brought the audience two parallel plenary sessions which covered the challenges and complexities of diagnosing and treating children/adolescents and adults with ADHD and psychiatric comorbid disorders; key publications in ADHD from the past year; ADHD and the impact on families; management strategies across the life-course; and sustaining optimal managent of ADHD.

Read more >



A selection of clinical seminars – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Across the 2-day meeting delegates were able to attend a range of clinical seminars which encompassed a wide range of subjects such as the new ASRS v1.2 screener, behavioural health in women, non-pharmacological and pharmacological treatment strategies, ADHD and psychiatric comorbidities in children, adolescents and adults, and strategies to help families living with ADHD. Here are some highlights.

Read more >





Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Takeda has no influence or control over the content of this third party website.

Continue Cancel